Tolerogenic Dendritic Cell Therapy for Rheumatoid Arthritis

Clinical trial NCT05251870 · UNKNOWN

Trial details

NCT number: NCT05251870
Sponsor: UMC Utrecht
Status: UNKNOWN
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Rheumatoid Arthritis

Start date: 2021-08-17
Primary completion: 2024-08-01
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.